News

If confirmed in additional laboratory research and clinical trials, the researchers’ study in mice engineered to have Parkinson’s disease symptoms could pave the way for a Parkinson’s disease therapy based on the hormone irisin.

Researchers have developed a new type of CAR T cell that can be turned off to prevent severe side effects related to the overstimulation of the immune system, such as cytokine release syndrome.

In a new study, researchers have uncovered a detailed mechanism by which tumors can skirt both the immune system and cancer therapies that leverage its power, such as genetically engineered CAR T cells.

Findings from genomic analysis of the novel monkeypox virus indicate that the recommended vaccinia virus-based vaccines will induce a strong immune response against the virus.

Researchers have developed a gene therapy that rescues cilia defects to treat a rare disease that causes blindness in early childhood.

A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has begun enrolling adult volunteers.

A new study has identified an association between influenza vaccine and a reduced risk of stroke. The research is published in the journal Neurology.

According to two clinical trials, boosting vitamin D levels in adults during the SARS-CoV-2 pandemic was not associated with protection against respiratory tract infections or COVID-19.

A new strategy for vaccinating against HIV, using adjuvants, has shown promise in a pre-clinical research study.

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published in the American Heart Association’s flagship journal Circulation.